Kimrun Kaur

MRes: Applied Sciences

Biomedical Science BSc (Hons)

[Kimrun Kaur @KaurKimrun]

Which blood cancer is more common in the UK?

[Kimrun Kaur @KaurKimrun]

There has been significant improvement in the treatment landscape over the past decade, however none of the drugs have curative potential and most patients become resistant, whereby they no longer respond to treatment. #myelomaawareness #bloodcancer #research

[Kimrun Kaur @KaurKimrun]

Current therapies for multiple myeloma aim to control symptoms, slow progression of the disease and improve quality of life. However, with such treatments the median survival rate of the patient is a mere 5 years and myeloma remains incurable. #myelomaawareness #bloodcancer

[Kimrun Kaur @KaurKimrun]

Multiple Myeloma is an incurable blood cancer, here are some of the characteristics of Myeloma #myelomaawareness #research #bloodcancer

[Kimrun Kaur @KaurKimrun]

Multiple Myeloma is actually the second most common haematological malignancy in the UK, with incidence rates expected to rise in the next 20 years. #myelomaawareness #bloodcancer #research